Ministry figures recently passed on to Citizens Commission on Human Rights, a psychiatric and human rights violations watchdog, show 621 kilograms of methylphenidate were issued in 2010, compared with 352 kilograms in 2009.
The 2010 figures show the steepest increase since surveillance on Ritalin and Concerta marketing in Israel began in 1993. The surveillance is required since these drugs contain the active ingredient methylphenidate, which is classified in Israel as a dangerous drug.
Ritalin, a central nervous system stimulant that affects chemicals in the brain and nerves, is used to treat attention deficit disorder (ADD ) and attention deficit hyperactivity disorder (ADHD ). Ritalin is also used in the treatment of a sleep disorder called narcolepsy (an uncontrollable desire to sleep ).
Ministry figures recently passed on to Citizens Commission on Human Rights, a psychiatric and human rights violations watchdog, show 621 kilograms of methylphenidate were issued in 2010, compared with 352 kilograms in 2009.